| Cell line name |
KUMA-3 |
|---|
| Synonyms |
Kuma-3 |
|---|
| Accession |
CVCL_SA77 |
|---|
| Resource Identification Initiative |
To cite this cell line use: KUMA-3 (RRID:CVCL_SA77) |
|---|
| Comments |
Population: Japanese. |
|---|
| Sequence variations |
|
|---|
| HLA typing |
Source: PubMed=10741724
| Class I | | HLA-A | A*24:02,11:01 |
|
|---|
| Disease |
Head and neck squamous cell carcinoma (NCIt: C34447) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=10741724
Eura M., Chikamatsu K., Katsura F., Obata A., Sobao Y., Takiguchi M., Song Y.-S., Appella E., Whiteside T.L., DeLeo A.B.
A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
Clin. Cancer Res. 6:979-986(2000) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_SA77
|
|---|
| Encyclopedic resources |
Wikidata; Q54900714
|
|---|
| Polymorphism and mutation databases |
IARC_TP53; 28405
|
|---|
| Entry history |
|---|
| Entry creation | 14-May-2018 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 9 |
|---|
